Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Richalet, M. Maignan, M. Rivera-Ch, I. Pham, F. Leon-Velarde (Bobigny, France; Lima, Peru). Acetazolamide, chronic mountain sickness and pulmonary hypertension. Eur Respir J 2008; 32: Suppl. 52, 3182

Member's Comments

No comment yet.

Related content which might interest you: High-altitude pulmonary hypertension: a pathophysiological entity to different diseases Source: Eur Respir J 2003 Dec 01;22(6):1019-1025 Year: 2003 Travel to high altitude with pre-existing lung disease Source: Eur Respir J 2007; 29: 770-792 Year: 2007 Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight Source: Eur Respir J 2005; 25: 725-730 Year: 2005 Exercise pathophysiology in patients with chronic mountain sickness Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Fitness for flying and diving Source: Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion Year: 2006 Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history Source: Eur Respir Rev 2009; 18: 170-173 Year: 2009 High-altitude disease Source: Respipedia Article Year: 2017 Pulmonary hypertension in COPD Source: Eur Respir J 2008; 32: 1371-1385 Year: 2008 Calcium channel activity in lowlanders and in highlanders with pulmonary hypertension due to chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 99s Year: 2002 Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics Source: Eur Respir J 2012; 40: 1401-1409 Year: 2012 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 The effects of national lockdown on incidence of acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Treatment of pulmonary hypertension in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313 Year: 2006 Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2007; 30: 922-927 Year: 2007 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 The rate of pulmonary thromboembolism in acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 Pulmonary hypertension in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 892-905 Year: 2003 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021